Baker Avenue Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$544K Sell
8,668
-19,153
-69% -$1.53M 0.01% 402
2025
Q4
$2.65M Buy
27,821
+1,190
+4% +$117K 0.06% 188
2025
Q3
$2.6M Buy
26,631
+543
+2% +$56.2K 0.06% 189
2025
Q2
$2.8M Sell
26,088
-1,410
-5% -$143K 0.08% 166
2025
Q1
$2.77M Buy
+27,498
New +$2.77M 0.09% 171
2023
Q4
Sell
-167
Closed -$8.82K 525
2023
Q3
$8.82K Sell
167
-53
-24% -$2.78K ﹤0.01% 790
2023
Q2
$11.9K Buy
220
+14
+7% +$731 ﹤0.01% 716
2023
Q1
$10.3K Sell
206
-29
-12% -$1.37K ﹤0.01% 760
2022
Q4
$10.9K Buy
+235
New +$10.2K ﹤0.01% 694
2019
Q3
Sell
-5,593
Closed -$240K 240
2019
Q2
$240K Buy
+5,593
New +$215K 0.02% 221
2017
Q2
Sell
-24,268
Closed -$604K 202
2017
Q1
$604K Buy
24,268
+1,823
+8% +$44.3K 0.08% 131
2016
Q4
$485K Buy
22,445
+2,220
+11% +$48.4K 0.07% 149
2016
Q3
$481K Buy
20,225
+655
+3% +$15.6K 0.07% 141
2016
Q2
$457K Sell
19,570
-390
-2% -$8.44K 0.07% 136
2016
Q1
$375K Sell
19,960
-3,640
-15% -$63.9K 0.06% 142
2015
Q4
$435K Buy
+23,600
New +$423K 0.06% 128

Other funds holding BSX